Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology

Journal of the American Academy of Dermatology
Alexander L FogelJoyce M C Teng

Abstract

Significant developments in the use of mammalian target of rapamycin (mTOR) inhibitors (mTORIs) as immunosuppressant and antiproliferative agents have been made. Recent advances in the understanding of the mTOR signaling pathway and its downstream effects on tumorigenesis and vascular proliferation have broadened the clinical applications of mTORIs in many challenging disorders such as tuberous sclerosis complex, pachyonychia congenita, complex vascular anomalies, and inflammatory dermatoses. Systemic mTORI therapy has shown benefits in these areas, but is associated with significant side effects that sometimes necessitate drug holidays. To mitigate the side effects of systemic mTORIs for dermatologic applications, preliminary work to assess the potential of percutaneous therapy has been performed, and the evidence suggests that percutaneous delivery of mTORIs may allow for effective long-term therapy while avoiding systemic toxicities. Additional large placebo-controlled, double-blinded, randomized studies are needed to assess the efficacy, safety, duration, and tolerability of topical treatments. The objective of this review is to provide updated information on the novel use of mTORIs in the management of many cutaneous disor...Continue Reading

References

Mar 17, 2004·Transplantation·Josep M CampistolJ Vicente Torregrosa
Jan 27, 2005·Investigative Ophthalmology & Visual Science·Young Sam KwonYoungsook Son
Feb 3, 2006·Annals of Neurology·David Neal FranzKerry R Crone
Jun 23, 2007·Journal of the American Academy of Dermatology·Kapila V Paghdal, Robert A Schwartz
Mar 29, 2008·Lymphatic Research and Biology·Farheen ShiraziJack L Arbiser
Apr 24, 2008·Nature Clinical Practice. Oncology·Deborah J MarshGlenn M Marshall
Nov 11, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·A SoriaC Francès
Jul 2, 2009·Journal of Chemical Biology·Lisa M Ballou, Richard Z Lin
Aug 21, 2009·Clinical Genitourinary Cancer·Mona GandhiMario Lacouture
Nov 21, 2009·Journal of the American Academy of Dermatology·Tina S ChenAmy E Gilliam
Jul 16, 2010·Experimental Dermatology·Melanie KremerBarbara S Schnierle
Aug 3, 2010·The Journal of Dermatological Treatment·Elizabeth Kaufman McNamaraAlan B Fleischer
Aug 6, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WolffErnst Holler
Aug 11, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Zuzana JedlickovaMichael Schleuning
Aug 24, 2010·Pediatric Blood & Cancer·Julie BlattDean S Morrell
Dec 24, 2010·Archives of Biochemistry and Biophysics·Jean Christopher ChamcheuHasan Mukhtar
Mar 30, 2011·Pediatric Blood & Cancer·Adrienne M HammillDenise M Adams
Apr 6, 2011·Pediatrics·Dana TiberioJohn R Phillips
Apr 19, 2011·Journal of the American Academy of Dermatology·Emily A GriffardMary Feldman
Apr 29, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·D Mark DaviesJulian R Sampson
Jul 8, 2011·Cancer Prevention Research·L Allyson CheckleyJohn DiGiovanni
Aug 13, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·R SalidoJ C Moreno-Giménez
Sep 16, 2011·Expert Review of Anticancer Therapy·David Neal Franz
Nov 1, 2011·Nature Reviews. Drug Discovery·Don BenjaminMichael N Hall
Mar 7, 2012·Pediatrics·Hasan YuksekkayaHatice Toy
May 23, 2012·Dermatology : International Journal for Clinical and Investigative Dermatology·L PeuvrelB Dréno
Jul 27, 2012·The New England Journal of Medicine·Sylvie EuvrardUNKNOWN TUMORAPA Study Group
Sep 11, 2012·Archives of Dermatological Research·Antonio Peramo, Cynthia L Marcelo
Oct 16, 2012·Journal of the American Academy of Dermatology·Angelique M Poot, Marcel F Jonkman
Nov 7, 2012·Cancer Prevention Research·Theresa D CarrLisa M Shantz

❮ Previous
Next ❯

Citations

Jul 30, 2016·Pediatric Dermatology·Alexander L FogelJoyce M C Teng
Nov 8, 2016·Journal of Pediatric Hematology/oncology·Dov C GoldenbergRolf Gemperli
Jun 24, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jia LiuZhong-Hou Han
Nov 4, 2016·Nature Communications·Xiaolei DingSabine A Eming
Jan 9, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Jinzhu MaoJuan Tao
Mar 5, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·M SamimiC Francès
Dec 3, 2016·Expert Review of Clinical Immunology·Cosimo BruniMarco Matucci-Cerinic
May 12, 2018·The British Journal of Dermatology·C B HoH S Shiah
Jan 29, 2020·Ophthalmic Plastic and Reconstructive Surgery·Marissa K ShojiSuzanne K Freitag
Jun 9, 2021·Expert Opinion on Therapeutic Patents·Han-Yue QiuMin Zhang
Jul 31, 2021·The Australasian Journal of Dermatology·Andrew W SwarbrickRachael S Foster

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

International Journal of Dermatology
V K SharmaS Kaur
Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
Liesbeth De WaeleDjalila Mekahli
Journal of Angiogenesis Research
Patrick A SingletonJoe Gn Garcia
© 2021 Meta ULC. All rights reserved